Trager James 4
4 · Nkarta, Inc. · Filed May 5, 2021
Insider Transaction Report
Form 4
Nkarta, Inc.NKTX
Trager James
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2021-05-03$3.89/sh+2,250$8,753→ 47,972 total - Sale
Common Stock
2021-05-03$31.64/sh−1,350$42,714→ 45,722 total - Sale
Common Stock
2021-05-03$31.64/sh−2,250$71,190→ 45,722 total - Exercise/Conversion
Stock Option (right to buy)
2021-05-03−2,250→ 57,662 totalExercise: $3.89Exp: 2029-09-05→ Common Stock (2,250 underlying)
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.
- [F2]This option originally covered 62,162 shares of NKTX common stock and was scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following July 1, 2020.